Novavax Global Commercial Operations and COVID-19 Vaccine Update

Status of regulatory authorizations globally Adult Vaccination (aged 18+) Authorizations received in priority markets¹ 27 EU Countries Great Britain novavax 1. As of March 2023. 2. Australia United States Canada Adolescent Vaccination (aged 12-17) Pediatric Vaccination (aged 7-11) + Includes authorizations in partnership with Serum Institute of India, SK bioscience, and Takeda. . Authorizations in 14 additional countries around the world2 Emergency Use Listing from the WHO © 2023 NOVAVAX. All rights reserved. 10

View entire presentation